Inventor

STAFFORD JEFFREY ALAN

US88 patents

⚠️ This page may combine multiple inventors who share the name “STAFFORD JEFFREY ALAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE QUANTICEL RES INC

35 patents

US11084793B2Aug 10, 2021

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC3 citations84

US10207999B2Feb 19, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations84

US10202381B2Feb 12, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations84

US10112940B2Oct 30, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations84

US10023543B2Jul 17, 2018

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations84

US9776974B2Oct 3, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations84

US9771329B2Sep 26, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC6 citations84

US9725441B2Aug 8, 2017

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations84

US10316016B2Jun 11, 2019

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations83

US10166227B2Jan 1, 2019

Bromodomain and extra-terminal protein inhibitor combination therapy

CELGENE QUANTICEL RES INC6 citations83

US10047069B2Aug 14, 2018

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC4 citations83

US9828358B2Nov 28, 2017

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC5 citations83

US11535616B2Dec 27, 2022

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations73

US11214542B2Jan 4, 2022

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10870634B2Dec 22, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10815234B2Oct 27, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations73

US10807956B2Oct 20, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10654810B2May 19, 2020

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations73

US10654830B2May 19, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10611763B2Apr 7, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC2 citations73

US10597376B2Mar 24, 2020

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC1 citations73

US10597365B2Mar 24, 2020

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10494371B2Dec 3, 2019

Bromodomain inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10385051B2Aug 20, 2019

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations73

US10208039B2Feb 19, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations73

US10179769B2Jan 15, 2019

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC1 citations73

US10030017B2Jul 24, 2018

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC4 citations73

US9908885B2Mar 6, 2018

Bromodomain inhibitors

CELGENE QUANTICEL RES INC4 citations73

US9822119B2Nov 21, 2017

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC3 citations73

US11464771B2Oct 11, 2022

Bromodomain and extra-terminal protein inhibitor combination therapy

CELGENE QUANTICEL RES INC2 citations72

US10703739B2Jul 7, 2020

Compositions comprising an inhibitor of lysine specific demethylase-1

CELGENE QUANTICEL RES INC2 citations72

US10576075B2Mar 3, 2020

Bromodomain and extra-terminal protein inhibitor combination therapy

CELGENE QUANTICEL RES INC1 citations72

US10807982B2Oct 20, 2020

Bromodomain inhibitors

CELGENE QUANTICEL RES INC2 citations70

US12172998B2Dec 24, 2024

Histone demethylase inhibitors

CELGENE QUANTICEL RES INC0 citations63

US11987560B2May 21, 2024

Inhibitors of lysine specific demethylase-1

CELGENE QUANTICEL RES INC0 citations63

QUANTICEL PHARMACEUTICALS INC

11 patents

US9255097B2Feb 9, 2016

Inhibitors of lysine specific demethylase-1

QUANTICEL PHARMACEUTICALS INC29 citations98

US8952151B2Feb 10, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC21 citations96

US9573930B2Feb 21, 2017

Inhibitors of lysine specific demethylase-1

QUANTICEL PHARMACEUTICALS INC15 citations93

US9447045B2Sep 20, 2016

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC20 citations93

US9085534B2Jul 21, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC8 citations93

US9115114B2Aug 25, 2015

Bromodomain inhibitors

QUANTICEL PHARMACEUTICALS INC12 citations92

US8987461B2Mar 24, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC13 citations91

US9676770B2Jun 13, 2017

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC5 citations84

US9643965B2May 9, 2017

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC6 citations84

US9133166B2Sep 15, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC10 citations84

US9107916B2Aug 18, 2015

Histone demethylase inhibitors

QUANTICEL PHARMACEUTICALS INC4 citations84

Quanticel Pharmaceuticals

1 patent

US9034900B2May 19, 2015

Bromodomain inhibitors

Quanticel Pharmaceuticals36 citations95

GLAXO WELLCOME INC

1 patent

US5665754ASep 9, 1997

Substituted pyrrolidines

GLAXO WELLCOME INC95 citations91

TAKEDA PHARMACEUTICAL

1 patent

US7795428B2Sep 14, 2010

Dipeptidyl peptidase inhibitors

TAKEDA PHARMACEUTICAL12 citations89

SMITHKLINE BEECHAM CORP

1 patent

US7189712B2Mar 13, 2007

1,3-Oxazole compounds for the treatment of cancer

SMITHKLINE BEECHAM CORP13 citations81

Showing the top 50 of 88 patents by PatentIndex Score.